NO842766L - Fremgangsmaate for fremstilling av faste farmasoeytiske preparater med forsinket frigjoering - Google Patents

Fremgangsmaate for fremstilling av faste farmasoeytiske preparater med forsinket frigjoering

Info

Publication number: NO842766L
Authority: NO; Norway
Prior art keywords: pharmaceutically acceptable; compound; oral compositions; compositions; range
Prior art date: 1983-07-07

Application number

NO842766A

Other languages

English (en)

Other versions

NO170753B (no

NO170753C (no

Inventor

David R Powell

Vithal K Patel

Original Assignee

Rowell Lab Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1983-07-07

Filing date

1984-07-06

Publication date

1985-01-08

1984-07-06 Application filed by Rowell Lab Inc filed Critical Rowell Lab Inc

1985-01-08 Publication of NO842766L publication Critical patent/NO842766L/no

1992-08-24 Publication of NO170753B publication Critical patent/NO170753B/no

1992-12-02 Publication of NO170753C publication Critical patent/NO170753C/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Sliding Valves (AREA)
Electroplating Methods And Accessories (AREA)
Mechanical Treatment Of Semiconductor (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO842766A 1983-07-07 1984-07-06 Fremgangsmaate for fremstilling av faste farmasoeytiske preparater med forsinket frigjoering NO170753C (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US06/511,605 US4539198A (en)	1983-07-07	1983-07-07	Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion: expanded range

Publications (3)

Publication Number	Publication Date
NO842766L true NO842766L (no)	1985-01-08
NO170753B NO170753B (no)	1992-08-24
NO170753C NO170753C (no)	1992-12-02

Family

ID=24035636

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO842766A NO170753C (no)	1983-07-07	1984-07-06	Fremgangsmaate for fremstilling av faste farmasoeytiske preparater med forsinket frigjoering

Country Status (14)

Country	Link
US (1)	US4539198A (no)
EP (1)	EP0131485B1 (no)
AT (1)	ATE55900T1 (no)
AU (1)	AU561633B2 (no)
CA (1)	CA1224417A (no)
DE (1)	DE3483072D1 (no)
DK (1)	DK162697C (no)
ES (1)	ES534096A0 (no)
FI (1)	FI842528A7 (no)
IL (1)	IL72089A (no)
IT (1)	IT1180193B (no)
NO (1)	NO170753C (no)
NZ (1)	NZ208393A (no)
ZA (1)	ZA845208B (no)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4960765A (en) *	1980-03-20	1990-10-02	Farmaceutisk Laboratorium Ferring A/S	Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
JPS57500432A (no) *	1980-03-20	1982-03-11
US4690824A (en) *	1983-07-07	1987-09-01	Redi-Rowell, Inc.	Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion: expanded range
GB8322007D0 (en) *	1983-08-16	1983-09-21	Wellcome Found	Pharmaceutical delivery system
USRE33994E (en) *	1983-08-16	1992-07-14	Burroughs Wellcome Co.	Pharmaceutical delivery system
US4851229A (en) *	1983-12-01	1989-07-25	Alza Corporation	Composition comprising a therapeutic agent and a modulating agent
US4751071A (en) *	1983-12-01	1988-06-14	Alza Corporation	Composition comprising salbutamol
US4777049A (en) *	1983-12-01	1988-10-11	Alza Corporation	Constant release system with pulsed release
DE3346571A1 (de) *	1983-12-23	1985-07-04	Bayer Ag, 5090 Leverkusen	Oral retardierte acetylsalicylsaeureformulierungen
IT1206166B (it) *	1984-07-26	1989-04-14	Sigma Tau Ind Farmaceuti	Dispositivo per rilasciare una sostanza in un fluido di dissoluzione con cinetica di ordine zero e procedimento per la sua preparazione
US4631305A (en) *	1985-03-22	1986-12-23	The Upjohn Company	Polymeric material as a disintegrant in a compressed tablet
EP0272265B1 (de) *	1985-09-25	1991-05-22	Gergely, Gerhard, Dr.	Zerfallstablette und verfahren zu ihrer herstellung
US4753801A (en) *	1985-10-25	1988-06-28	Eli Lilly And Company	Sustained release tablets
AU607690B2 (en) *	1985-12-24	1991-03-14	Marion Laboratories, Inc.	Use of synthetic sulfated saccharides to enhance wound healing
US6482516B1 (en) *	1993-07-20	2002-11-19	Banner Pharmacaps, Inc.	Enrobed tablet
MX9300110A (es) *	1992-01-13	1994-07-29	Gerhard Gergely	Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
US6129930A (en)	1993-09-20	2000-10-10	Bova; David J.	Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6818229B1 (en)	1993-09-20	2004-11-16	Kos Pharmaceuticals, Inc.	Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6080428A (en)	1993-09-20	2000-06-27	Bova; David J.	Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6676967B1 (en)	1993-09-20	2004-01-13	Kos Pharmaceuticals, Inc.	Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6746691B2 (en)	1993-09-20	2004-06-08	Kos Pharmaceuticals, Inc.	Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US5609883A (en) *	1994-09-16	1997-03-11	Advanced Technology Pharmaceuticals Corporation	Compressed tablet transitory lubricant system
HUP0104606A3 (en) *	1998-12-18	2003-01-28	Basf Ag	A pharmaceutical mixture comprising a profen
US6726929B1 (en)	1998-12-18	2004-04-27	Basf Aktiengesellschaft	Pharmaceutical mixture comprising a profen
US8545880B2 (en) *	1999-02-26	2013-10-01	Andrx Pharmaceuticals, Llc	Controlled release oral dosage form
US6210716B1 (en)	1999-02-26	2001-04-03	Andrx Pharmaceuticals, Inc.	Controlled release bupropion formulation
JP2003508420A (ja)	1999-09-02	2003-03-04	ノストラム・ファーマスーティカルズ・インコーポレイテッド	経口投与に適した、制御された放出の経口用量
US6733780B1 (en)	1999-10-19	2004-05-11	Genzyme Corporation	Direct compression polymer tablet core
US9522217B2 (en)	2000-03-15	2016-12-20	Orbusneich Medical, Inc.	Medical device with coating for capturing genetically-altered cells and methods for using same
US8088060B2 (en)	2000-03-15	2012-01-03	Orbusneich Medical, Inc.	Progenitor endothelial cell capturing with a drug eluting implantable medical device
AU2001285311B2 (en)	2000-08-29	2005-09-15	Biocon, Ltd	Immunoregulatory compounds, derivatives thereof and their use
CA2359812C (en) *	2000-11-20	2004-02-10	The Procter & Gamble Company	Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
US6555581B1 (en)	2001-02-15	2003-04-29	Jones Pharma, Inc.	Levothyroxine compositions and methods
KR20040100835A (ko) *	2001-02-15	2004-12-02	킹 파머슈티칼스 리서치 앤드 디벨로프먼트 아이엔씨	안정된 제약및 갑상선 내분비 호르몬 구성물 및 그제조방법
US20030224047A1 (en) *	2001-02-15	2003-12-04	Franz G. Andrew	Levothyroxine compositions and methods
US20030032675A1 (en) *	2001-02-15	2003-02-13	Franz G. Andrew	Manufacture of thyroid hormone tablets having consistent active moiety amounts
US20030198671A1 (en) *	2001-08-10	2003-10-23	Franz G. Andrew	Levothyroxine compositions having unique plasma AUC properties
US20030198667A1 (en) *	2001-08-10	2003-10-23	Franz Andrew G.	Methods of producing dispersible pharmaceutical compositions
US20030190349A1 (en) *	2001-08-10	2003-10-09	Franz G. Andrew	Methods of stabilizing pharmaceutical compositions
US20030180353A1 (en) *	2001-08-10	2003-09-25	Franz G. Andrew	Stabilized pharmaceutical compositions
US7101569B2 (en)	2001-08-14	2006-09-05	Franz G Andrew	Methods of administering levothyroxine pharmaceutical compositions
US20030199587A1 (en) *	2001-08-14	2003-10-23	Franz G. Andrew	Levothyroxine compositions having unique Cmax properties
US20030198672A1 (en) *	2001-08-14	2003-10-23	Franz G. Andrew	Levothyroxine compositions having unique triidothyronine plasma AUC properties
US20030195253A1 (en) *	2001-08-14	2003-10-16	Franz G. Andrew	Unadsorbed levothyroxine pharmaceutical compositions, methods of making and methods of administration
US20030203967A1 (en) *	2001-08-14	2003-10-30	Franz G. Andrew	Levothyroxine compositions having unique Tmax properties
US20030199586A1 (en) *	2001-08-14	2003-10-23	Franz G. Andrew	Unique levothyroxine aqueous materials
US8048924B2 (en)	2001-08-29	2011-11-01	Biocon Limited	Methods and compositions employing 4-aminophenylacetic acid compounds
US20030175337A1 (en) *	2001-10-29	2003-09-18	Franz G. Andrew	Levothyroxine compositions having unique triiodothyronine Tmax properties
US6893660B2 (en) *	2002-11-21	2005-05-17	Andrx Pharmaceuticals, Inc.	Stable pharmaceutical compositions without a stabilizer
NZ551836A (en)	2004-07-02	2008-07-31	Meiji Dairies Corp	Solid milk and method of producing the same
US7932366B2 (en)	2004-07-07	2011-04-26	Biocon Limited	Synthesis of azo bonded immunoregulatory compounds
EP1784166B1 (en) *	2004-09-01	2009-03-04	The Procter and Gamble Company	Compositions comprising 5-amino-2-hydroxybenzoic acid and a reducing sugar
US7985418B2 (en) *	2004-11-01	2011-07-26	Genzyme Corporation	Aliphatic amine polymer salts for tableting
US8986669B2 (en)	2005-09-02	2015-03-24	Genzyme Corporation	Method for removing phosphate and polymer used therefore
KR101547925B1 (ko)	2005-09-15	2015-08-27	젠자임 코포레이션	아민 중합체에 대한 샤셋 제형
US8497258B2 (en)	2005-11-12	2013-07-30	The Regents Of The University Of California	Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US20080075785A1 (en) *	2006-09-22	2008-03-27	San-Laung Chow	Controlled release hydrogel formulation
US20110165236A1 (en) *	2006-09-22	2011-07-07	Biokey, Inc.	Controlled release hydrogel formulation
WO2008042222A2 (en)	2006-09-29	2008-04-10	Genzyme Corporation	Amide dendrimer compositions
EP2120972A1 (en)	2006-12-14	2009-11-25	Genzyme Corporation	Amido-amine polymer compositions
US20090036414A1 (en) *	2007-08-02	2009-02-05	Mutual Pharmaceutical Company, Inc.	Mesalamine Formulations
WO2009064458A2 (en)	2007-11-13	2009-05-22	Meritage Pharma, Inc.	Compositions for the treatment of inflammation of the gastrointestinal tract
WO2009078958A1 (en) *	2007-12-14	2009-06-25	Genzyme Corporation	Coated pharmaceutical compositions
US20110172249A1 (en) *	2008-09-03	2011-07-14	Takeda Pharmaceutical Company Limted	Method for improving absorbability of preparation, and preparation having improved absorbability
EP2440210A4 (en)	2009-06-12	2014-01-29	Meritage Pharma Inc	METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES
CA2797809A1 (en)	2010-04-30	2011-11-03	Takeda Pharmaceutical Company Limited	Enteric tablet
EP2564838A4 (en)	2010-04-30	2014-06-04	Takeda Pharmaceutical	ENTERICIAN TABLET
DE102010033527A1 (de)	2010-08-05	2012-02-09	Acino Pharma Ag	Quetiapin-Tabletten
EP2425826A1 (en)	2010-09-01	2012-03-07	Disphar International B.V.	Mesalazine tablet having improved dissolution
DE102011115690A1 (de)	2011-10-11	2013-04-11	Acino Pharma Ag	Quetiapin enthaltende Formulierungen
ITUA20162293A1 (it)	2016-04-05	2017-10-05	Sofar Spa	Processo per formulazioni solide di mesalazina
EP3662898A1 (en) *	2018-12-07	2020-06-10	Tillotts Pharma AG	Solid composition comprising mesalazine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4361545A (en) *	1979-05-21	1982-11-30	Rowell Laboratories, Inc.	Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion
US4264573A (en) *	1979-05-21	1981-04-28	Rowell Laboratories, Inc.	Pharmaceutical formulation for slow release via controlled surface erosion
FR2471186A1 (fr) *	1979-12-10	1981-06-19	Roussel Uclaf	Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
JPS57500432A (no) *	1980-03-20	1982-03-11

1983
- 1983-07-07 US US06/511,605 patent/US4539198A/en not_active Expired - Lifetime
1984
- 1984-05-28 CA CA000455307A patent/CA1224417A/en not_active Expired
- 1984-05-31 AU AU28898/84A patent/AU561633B2/en not_active Ceased
- 1984-06-06 EP EP84401152A patent/EP0131485B1/en not_active Expired - Lifetime
- 1984-06-06 NZ NZ208393A patent/NZ208393A/en unknown
- 1984-06-06 DE DE8484401152T patent/DE3483072D1/de not_active Expired - Fee Related
- 1984-06-06 AT AT84401152T patent/ATE55900T1/de not_active IP Right Cessation
- 1984-06-13 IL IL72089A patent/IL72089A/xx not_active IP Right Cessation
- 1984-06-21 FI FI842528A patent/FI842528A7/fi not_active Application Discontinuation
- 1984-07-02 IT IT21720/84A patent/IT1180193B/it active
- 1984-07-06 NO NO842766A patent/NO170753C/no not_active IP Right Cessation
- 1984-07-06 ZA ZA845208A patent/ZA845208B/xx unknown
- 1984-07-06 DK DK333884A patent/DK162697C/da not_active IP Right Cessation
- 1984-07-06 ES ES534096A patent/ES534096A0/es active Granted

Also Published As

Publication number	Publication date
DE3483072D1 (de)	1990-10-04
IT1180193B (it)	1987-09-23
DK333884D0 (da)	1984-07-06
EP0131485B1 (en)	1990-08-29
EP0131485A2 (en)	1985-01-16
AU2889884A (en)	1985-01-10
DK162697B (da)	1991-12-02
DK333884A (da)	1985-01-08
AU561633B2 (en)	1987-05-14
IL72089A0 (en)	1984-10-31
IT8421720A0 (it)	1984-07-02
DK162697C (da)	1992-04-21
ATE55900T1 (de)	1990-09-15
ZA845208B (en)	1985-03-27
NZ208393A (en)	1987-03-31
NO170753B (no)	1992-08-24
US4539198A (en)	1985-09-03
IT8421720A1 (it)	1986-01-02
IL72089A (en)	1987-09-16
NO170753C (no)	1992-12-02
EP0131485A3 (en)	1986-08-06
ES8600053A1 (es)	1985-10-01
ES534096A0 (es)	1985-10-01
FI842528A0 (fi)	1984-06-21
FI842528A7 (fi)	1985-01-08
CA1224417A (en)	1987-07-21

Publication	Publication Date	Title
NO170753C (no)	1992-12-02	Fremgangsmaate for fremstilling av faste farmasoeytiske preparater med forsinket frigjoering
IL111647A0 (en)	1995-01-24	Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles, their preparation and pharmaceutical compositions containing them
ES8603870A1 (es)	1986-01-01	Un procedimiento para la preparacion de derivados de 2,2'-iminobisetanol.
IT1282352B1 (it)	1998-03-20	Composizione farmaceutica, in particolare essiccata mediante congelamento, per somministrazione orale di ondansetron e metodo per
EP0254067A3 (en)	1988-09-14	Composition for metastasis prevention
DK0385582T3 (da)	1992-09-14	Nifedipin-holdige farmaceutiske præparater og fremgangsmåde til fremstilling heraf
FI945081A0 (fi)	1994-10-28	Stabiili hydratoitu kefalosporiinikuivajauhe oraaliseen suspensioformulaatioon
CA2450359A1 (en)	2003-06-05	Dosage regimen and pharmaceutical composition for emergency contraception
BG105436A (en)	2001-11-30	Pharmaceutical compositions comprising entacapone or nitecapone as well as a cross-linked cellulpse derivative
FR2712807B1 (fr)	1996-02-23	Composition solide mucoadhésive, thérapeutique ou hygiénique, pour administration par application sur la muqueuse buccale ou nasale .
IL102814A0 (en)	1993-01-31	Pyrazine derivatives,their preparation and pharmaceutical compositions comprising them
GB1418208A (en)	1975-12-17	Pharmaceutical compositions
IE894049L (en)	1990-06-22	Therapeutically active substituted benzimidazole and process¹for its preparation
FI921809A0 (fi)	1992-04-23	Foerfarande foer framstaellning av en tablett- eller dragekomposition, som innehaoller en foer vaerme, ljus och fuktighetkaenslig aktiv ingrediens med monoklinisk kristallstruktur.
FI850828A0 (fi)	1985-02-28	Nya (8s)-8 -fluoroerytromycinderivat, foerfarande foer framstaellning av dessa och farmaceutiska sammansaettningar innehaollande dem.
CA2135179A1 (en)	1993-11-11	Pharmaceutical Compositions of Alkylsulphonamides 5HT1 Agonists for Rectal Administration
DE59913493D1 (de)	2006-07-06	Zweiphasige Zusammensetzung mit Tramadol
KR910019625A (ko)	1991-12-19	뼈의 무기질 소실을 억제하는 방법
GB1354451A (en)	1974-06-05	Halogen-substituted phenyl-alkylamines and their derivatives
Kiesel et al.	1994	Prevention of diabetes in BB rats by an E. coli extract(OM-89)
DK0483320T3 (da)	1995-01-30	Farmaceutiske sammensætninger med forlænget frigivelse til peroral indgivelse og fremgangsmåde til fremstilling deraf
ES342394A1 (es)	1968-09-16	Procedimiento para la produccion de nuevas 2-bencilamino-i-mida-zolinas-(2).
KR910002455A (ko)	1991-02-25	아크릴산 유도체를 함유하는 제약 조성물 및 의약으로서 이들의 사용
TH59782A3 (th)	2003-12-04	สารผสมของกาแลนแทมีนชนิดปลดปล่อยที่มีการควบคุม
JO1653B1 (en)	1991-11-27	The current benzimidazole is a therapeutically active method for preparing it

Legal Events

Date	Code	Title	Description
2001-03-05	MM1K	Lapsed by not paying the annual fees	Free format text: LAPSED IN JANUARY 2001